Consequences of COVID-19 on the respiratory, coagulation, immune and endocrine system and association with bacterial infections among patients treated in the intensive care unit.

Not Applicable

Completed

• Conditions: COVID-19; Blood - Clotting disorders; Renal and Urogenital - Kidney disease; Respiratory infection; Renin-angiotensin-aldosterone system dysfunction; Respiratory - Other respiratory disorders / diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders; Coagulation disorders; Metabolic and Endocrine - Metabolic disorders; Acute kidney injury

• Registration Number: ACTRN12621001300864
• Lead Sponsor: Patrycja Lesnik, MD, PhD

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-07-31
• Study Start: 2021-09-27
• Last Update Posted: 4 October 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 132

Inclusion Criteria

1.Aged between 18 and 90 years
2.Patients with confirmed COVID-19 hospitalized in the ICU
3.The obtained consent to participate in the study

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified